Food allergy drug developer Alladapt raised $119M in new funding
June 22, 2022 at 18:52 PM EDT
The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.